Description: Emerging Trends in Cancer Pharmacology: From Molecular Targets to Personalized Medicine gives readers a comprehensive and up-to-date resource on the latest developments and trends in the field of cancer pharmacology. It serves as a valuable reference for researchers, scientists, clinicians, and other professionals involved in cancer research, pharmacology, oncology, and personalized medicine. In recent years, there have been significant breakthroughs in understanding the molecular mechanisms of cancer and the development of targeted therapies. Additionally, personalized medicine has emerged as a promising approach to tailor treatments based on an individual's genetic profile, tumor characteristics, and other factors. These developments have the potential to revolutionize cancer treatment and improve patient outcomes. This book covers such developments.
Brief description:
Professor Tapan Behl is based at Amity School of Pharmaceutical Sciences, Amity University, Sahibzada Ajit Singh Nagar, Punjab, India. Dr. Tapan Behl completed his doctoral studies from Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India and thereafter worked as Post-Doctoral Researcher. His areas of interest include diabetes and associated complications, molecular pharmacology and neuropathic pain and its complications. Dr. Behl has published more than 400 research and review papers in International and National journals. He has also published International books and is continuously engaged in exploring the molecular mechanisms in diabetes and related complications, rheumatoid arthritis and obesity.